CYP3A4 also plays a secondary role, creating potential interactions with azole antifungals, macrolide antibiotics, and grapefruit juice
Injection technique GLP-1 injections are administered subcutaneously, typically once a week
If you dont address these underlying hormone issues, losing weight, (and keeping it off), can feel impossible
However, an important shift is occurring in clinical practice: we are recognizing patients with socalled lean MASLD and questioning whether our traditional therapeutic frameworks adequately address the full spectrum of disease
(CPS)" "R12.5: All patients taking GLP-1 agonists should be considered as at risk of having a full stomach despite a lack of gastrointestinal symptoms
PubMed Central, Xia, Qing, et al